Ocean Biomedical (OCEA) just unveiled an update.
Ocean Biomedical has been notified by Nasdaq of non-compliance due to its failure to file the mandatory Quarterly Report on time, linked to earlier delays in filing its annual report. While trading on Nasdaq remains unaffected for now, the company must submit a compliance plan by September 3, 2024, and file all overdue reports by October 14, 2024. Ocean Biomedical intends to resolve these filings promptly and has issued a press release regarding this notice.
Learn more about OCEA stock on TipRanks’ Stock Analysis page.
